Overview

• The Series B round, led by Point72 Private Investments with participation from Blackbird, Headline and Latitude/LocalGlobe, brings Heidi’s total funding to nearly $100 million.
• Heidi says the new capital will accelerate expansion in the US, UK and Canada and support plans to double its UK workforce, with regional buildouts also targeted in Hong Kong or Singapore.
• According to the company, its tools are used by more than 60% of NHS GPs, support roughly 340,000 UK consultations each week and save about 3 million clinician hours annually in the UK, with over 70 million global consultations in the past 18 months.
• The company announced senior hires to drive growth, naming former Plaid executive Paul Williamson as chief revenue officer and former Microsoft chief medical officer Dr. Simon Kos as global chief medical officer.
• Heidi’s product automates clinical documentation and follow-ups as an AI medical scribe, and it introduced an agent that can call patients on behalf of clinicians, with NHS deployments including Modality Partnership and pilots at major hospital groups.